This culture helped shape Dr. Tom Price, the orthopedic surgeon and Georgia congressman who is Donald Trump’s nominee for secretary of health and human services. Last March, Price announced his opposition to a sensible Medicare proposal to limit the money doctors could make from drugs they prescribe their patients. Price has put the interests of drug companies above those of taxpayers and patients — and invested in those drug companies on the side. In his defense, a spokesman for Price has said that his broker bought the Zimmer stock and Price didn’t find out until later. His preferred replacement of Obamacare would reduce health care benefits for sicker, poorer and older Americans.

Source: New York Times February 07, 2017 08:21 UTC